Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

News > All

Total search results: 9799 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 32 33 34 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Epigenomics AG. (4/27/16). "Press Release: Epigenomics Announces Commercial Launch of Epi proColon in the U.S.". Berlin & Germantown, MD. 2016-04-27
Editas Medicine, Inc.. (4/27/16). "Press Release: Editas Medicine to Present at Deutsche Bank 41st Annual Health Care Conference". Cambridge, MA. 2016-04-27
Adaptimmune Therapeutics plc. (4/27/16). "Press Release: Adaptimmune to Present at the Deutsche Bank Securities 41st Annual Health Care Conference". 2016-04-27
High-Tech Gründerfonds Management GmbH. (4/27/16). "Press Release: Bentekk GmbH Receives Seed Funding to Develop the Market with Gas Measurement Technology". 2016-04-27
Evotec AG. (4/26/16). "Press Release: Evotec and Ex Scientia Announce Partnership to Discover Bispecific Small Molecule Immuno-oncology Therapeutics". Hamburg & Dundee. 2016-04-26
Stratec Biomedical AG. (4/26/16). "Press Release: Stratec Reports on First Three Months of 2016". Birkenfeld. 2016-04-26
Eurofins. (4/25/16). "Press Release: Eurofins Achieves 48% Revenue growth and over 10% Organic Growth in Q1 2016". 2016-04-25
Wilex AG. (4/25/16). "Press Release: Wilex AG Successfully Completes Capital Increase". Munich. 2016-04-25
Ionicon Analytik GmbH. (4/22/16). "Press Release: Ionicon Launches Autosampler for High Throughput PTR-MS Measurements". Innsbruck. 2016-04-22
Novartis AG. (4/21/16). "Press Release: Novartis Delivered Solid Q1 Despite Gleevec Loss of Exclusivity, Investing Behind New Launches for Long-term Growth". Basel. 2016-04-21
Ablynx N.V.. (4/21/16). "Press Release: Ablynx to Receive an €8 Million Milestone as Boehringer Ingelheim Starts a Phase I Study with an anti-CX3CR1 Nanobody". Ghent & Ingelheim. 2016-04-21
MorphoSys AG. (4/21/16). "Press Release: MorphoSys Provides Update on Results From Partner's Phase 2b/3 RESILIENT Study of Bimagrumab. Bimagrumab Did Not Meet Its Primary Endpoint in Patients with sIBM". 2016-04-21
Aptuit, LLC. (4/21/16). "Press Release: Aptuit Announces Acquisition of Exquiron Biotech AG". Greenwich, CT. 2016-04-21
Illumina, Inc.. (4/21/16). "Press Release: Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents". San Diego, CA. 2016-04-21
Specialized Medical Services-Oncology B.V. (SMS-Oncology). (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". 2016-04-21
F-Star Biotechnology Ltd.. (4/21/16). "Press Release: F-star to Present at Key Conferences in April and May 2016". Cambridge. 2016-04-21
iTeos Therapeutics S.A.. (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". Bilthoven. 2016-04-21
Second Genome, Inc.. (4/20/16). "Press Release: Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund". South San Francisco, CA. 2016-04-20
Formycon AG. (4/20/16). "Press Release: Formycon Ends 2015 Fiscal Year with Successful Results [Not for USA, Canada, Australia, Japan, et al.]". Munich. 2016-04-20
Saphetor S.A.. (4/20/16). "Press Release: Saphetor Signs Collaboration with Lausanne University Hospital (CHUV)". Lausanne. 2016-04-20
Enterome Bioscience S.A.. (4/20/16). "Press Release: Enterome Raises €14.5 Million in Series C Financing Round. Nestlé Health Science Invests alongside Existing Investors". Paris & Boston, MA. 2016-04-20
R-Biopharm AG. (4/19/16). "Press Release: R-Biopharm AG to Collaborate with HMNC Brain Health on Complementary Diagnostic Test for Optimization of Depression Treatment". Darmstadt. 2016-04-19
G-Therapeutics B.V.. (4/19/16). "Press Release: G-Therapeutics Raises EUR 36 Million to Develop Novel Neuro-stimulation Therapy for Spinal Cord Injury". Eindhoven & Lausanne. 2016-04-19
Gimv. (4/19/16). "Press Release: Gimv Invests EUR 6 Million in G-Therapeutics as Part of a Total Series A Financing of EUR 26 Million". 2016-04-19
Roche. (4/19/16). "Press Release: Roche Reports Solid Sales Growth in the First Quarter of 2016. Group Sales up 4%1 at Constant Exchange Rates, 5% in Swiss Francs". Basel. 2016-04-19
Evotec AG. (4/19/16). "Press Release: Evotec and Pierre Fabre Sign Multi-year Compound Management Agreement". Hamburg. 2016-04-19
ProBioGen AG. (4/19/16). "Press Release: ProBioGen and Eucodis Sign Agreement to Commercialize C-LiNK, a Novel Antibody Drug Conjugation Technology". Berlin & Vienna. 2016-04-19
Analytik Jena AG. (4/19/16). "Press Release: Analytik Jena Sells Site in Eisfeld. New Investor Acquiring Entire Optics Business Unit as Well as Component Production for Analytical Technology". Jena & Eisfeld. 2016-04-19
MorphoSys AG. (4/18/16). "Press Release: MorphoSys Licensing Partner GSK Starts Phase 2 Study with GSK3196165 (MOR103) in Hand Osteoarthritis". 2016-04-18
Oxford BioTherapeutics Ltd.. (4/18/16). "Press Release: Boehringer Ingelheim Exercises Option on Second Oncology Target Using Oxford BioTherapeutics’ OGAP System". Oxford. 2016-04-18
Promethera Biosciences S.A.. (4/18/16). "Press Release: Promethera Biosciences Acquires Key Assets of Cytonet to Create the Global Leader in Regenerative Medicine and Cell Therapy for Liver Diseases". Mont-Saint-Guibert. 2016-04-18
Agena Bioscience, Inc.. (4/18/16). "Press Release: Agena Bioscience Launches High Sensitivity and Multiplexed Genetic Testing Product for Targeted Analysis of Solid Tumors". San Diego, CA. 2016-04-18
Euronext N.V.. (4/15/16). "Press Release: Euronext Welcomes Swiss Biotechnology Pioneer GeNeuro to Paris Market. Raises €33 Million, Market Capitalisation Totals €190 Million". Paris. 2016-04-15
WuXi AppTec. (4/15/16). "Press Release: WuXi AppTec Acquires Crelux". Munich. 2016-04-15
BioKryo GmbH. (4/15/16). "Press Release: BioKryo GmbH Obtains the American Association of Blood Banks (AABB) Accreditation". 2016-04-15
Agena Bioscience, Inc.. (4/14/16). "Press Release: Agena Bioscience and Horizon Discovery to Launch iPLEX Reference Standards for the MassARRAY System". San Diego, CA & Cambridge. 2016-04-14
GeNeuro S.A.. (4/14/16). "Press Release: GeNeuro Sets Offer Price at €13 per Share [Not for Australia, Canada or Japan]". Geneva. 2016-04-14
Qiagen N.V.. (4/14/16). "Press Release: Qiagen Launches Streamlined Bioinformatics for RNA Sequencing of Liquid Biopsies. RNA-seq Explorer Solution Generates Clear Insights for Cancer »Omics« Analyses". Hilden & Germantown, MD. 2016-04-14
Kymab Ltd.. (4/14/16). "Press Release: Kymab Appoints Leaders in Immuno-Oncology, Infectious Disease and Blood Disorders". Cambridge. 2016-04-14
Tecan Group Ltd.. (4/13/16). "Press Release: Annual General Meeting 2016 – Tecan Shareholders Endorse All Motions Proposed by the Board of Directors". Männedorf. 2016-04-13
Epigenomics AG. (4/13/16). "Press Release: Epigenomics Receives FDA Approval for Epi proColon". Berlin & Germantown, MD. 2016-04-13
Qiagen N.V.. (4/13/16). "Press Release: Qiagen Partners to Develop Novel Companion Diagnostic in Lung Cancer. Collaboration with Mirati Therapeutics Targets MET Gene Mutations to Personalize Treatment". Hilden & Germantown, MD. 2016-04-13
Evolva Holding S.A.. (4/13/16). "Press Release: Evolva Proposes Gerard Hoetmer as New Board Member". 2016-04-13
Curetis N.V.. (4/12/16). "Press Release: Curetis Publishes Full-year 2015 Financial Results and Introduces 2016 Guidance". Amsterdam & Holzgerlingen. 2016-04-12
Forbion Capital Partners. (4/12/16). "Press Release: Forbion Closes Third Life Sciences Fund, FCF III, Raising over USD200M". Naarden & Munich. 2016-04-12
KWS Saat SE. (4/12/16). "Press Release: KWS to Fully Focus on Hybrid Potato Breeding and Divest its Conventional Seed Potato Business". 2016-04-12
Numares AG. (4/12/16 [ca.]). "Press Release: CEO Dr. Volker Pfahlert Presented Numares at the 15th Annual Needham Healthcare Conference". 2016-04-12
Nordic Nanovector ASA. (4/11/16). "Press Release: Nordic Nanovector Enters Collaboration with Paul Scherrer Institute to Develop New Antibody Radionuclide Conjugates for Treating Leukaemias". Oslo. 2016-04-11
STAT-Diagnostica & Innovation S.L.. (4/11/16). "Press Release: STAT-Diagnostica Announces 25 Million Euros in Series C Financing Led by Gilde Healthcare. Funding Will Be Used to Accelerate Go-to-Market Strategy". Barcelona. 2016-04-11
Genedata AG. (4/11/16). "Press Release: Genedata Announces the Release of Genedata Bioprocess – New Workflow Platform for Biopharmaceutical Development". Basel. 2016-04-11
Bruker Corporation. (4/11/16). "Press Release: Bruker Introduces Important MALDI Biotyper Enhancements at ECCMID 2016 – New Disposable MBT Biotargets 96, MBT Subtyping and Carbapenem Resistance Tests". Amsterdam. 2016-04-11
Evolva Holding S.A.. (4/11/16). "Press Release: Evolva to Co-develop Next-generation Materials with US Navy". 2016-04-11
Boehringer Ingelheim. (4/7/16). "Press Release: Giotrif (afatinib) Approved in Europe as New Oral Treatment Option for Patients with Squamous Cell Carcinoma of the Lung". Ingelheim. 2016-04-07
Kiadis Pharma N.V.. (4/7/16). "Press Release: Kiadis Pharma Proposes Robert Soiffer and Berndt Modig as Its New Supervisory Board Members". Amsterdam. 2016-04-07
MorphoSys AG. (4/7/16). "Press Release: MorphoSys and Galapagos Initiate Phase 1 Study in Joint Antibody Program MOR106". 2016-04-07
Analytik Jena AG. (4/7/16). "Press Release: Analytik Jena Launches a New Model for the PlasmaQuant® PQ 9000 Series of ICP-OES Instruments". Jena. 2016-04-07
High-Tech Gründerfonds Management GmbH. (4/7/16). "Press Release: Cunesoft Receives a Seven-digit Series-A Financing from Occident Group, High-Tech-Gruenderfonds and Bayern Kapital". 2016-04-07
BioSilta Ltd.. (4/6/16). "Press Release: BioSilta Ltd Acquires Worldwide Rights to CyDisCo Technology from University of Oulu to Produce Proteins with Multi-industry Applications". Cambridge. 2016-04-06
Lumos Pharma. (4/6/16). "Press Release: Lumos Pharma Raises $34 Million in Series B Financing". Austin, TX. 2016-04-06
Thermosome GmbH. (4/6/16). "Press Release: Thermosome Receives €2.7m Research Grant from the German Federal Ministry of Education and Research (BMBF)". Martinsried. 2016-04-06
Thermosome GmbH. (4/6/16). "Press Release: Thermosome Raises €4.6m with First financing Round and a Research Grant from the German Government". Martinsried. 2016-04-06
Pressure BioSciences, Inc.. (4/6/16). "Press Release: Company Reports Increases in Total/Products/Grant Revenue & Product Gross Margins". South Easton, MA. 2016-04-06
Meiogenix S.A.S.. (4/6/16). "Press Release: Meiogenix Announces a Licensing Agreement with Bayer to Apply SpiX Technology in Crops". Paris. 2016-04-06
Merck KGaA. (4/6/16). "Press Release: Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy Test for Colorectal Cancer Patients". Darmstadt. 2016-04-06
Bruker Corporation. (4/6/16). "Press Release: The Weizmann Institute of Science Selects Bruker GigaHertz NMR Technology to Enable Advanced Structural Biology Research". Rehovot & Billerica, MA. 2016-04-06
Markes International Ltd.. (4/5/16). "Press Release: New Paper in Analytical Chemistry – Select-eV Unravels the Composition of Complex Motor Oils". 2016-04-05
Evolva Holding S.A.. (4/5/16). "Press Release: Evolva Gains Exclusive License to Develop and Commercialise Nootkatone Globally for Pest Control". 2016-04-05
Qiagen N.V.. (4/5/16). "Press Release: Qiagen Partners with IT Leaders on Novel Infrastructure for Genomics". Boston, MA & Hilden. 2016-04-05
Proteome Sciences plc. (4/5/16). "Press Release: Deep Protein Profiling Key to Improving Cancer Treatment". Cobham. 2016-04-05
Metabomed Ltd.. (4/4/16). "Press Release: Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing". Yavne. 2016-04-04
Anergis S.A.. (4/4/16). "Press Release: Anergis Closes CHF 5 Million Financing Round Extension to Conduct Large-Scale ATIBAR Trial with Ultra-Fast Allergy Immunotherapy AllerT". Epalinges. 2016-04-04
Boehringer Ingelheim. (4/4/16). "Press Release: Interim Phase III Data Show Praxbind (Idarucizumab) Reverses Dabigatran (Pradaxa) in Emergency Situations". Ingelheim. 2016-04-04
Agena Bioscience, Inc.. (4/4/16). "Press Release: Agena Bioscience Launches In Vitro Diagnostic Tests for Lung and Colon Cancer in Europe. Company Achieves CE-IVD mark and Enters Routine Molecular Diagnostics Market". San Diego, CA & Hamburg. 2016-04-04
MorphoSys AG. (4/4/16). "Press Release: Ad hoc – MorphoSys Sues Janssen Biotech and Genmab for Patent Infringement". 2016-04-04
Medigene AG. (4/4/16). "Press Release: Medigene Sells Partial Stake in Immunocore". Martinsried. 2016-04-04
Stratec Biomedical AG. (4/1/16). "Press Release: Stratec Completes Acquisition of Diatron". Birkenfeld. 2016-04-01
Medigene AG. (4/1/16). "Press Release: Medigene Announces Start of Phase II Trial with DC Vaccines and Upcoming Milestone Payment". Martinsried. 2016-04-01
Endress+Hauser AG. (4/1/16). "Press Release: Endress+Hauser Completes Takeover of Analytik Jena. Remaining Minority Shareholders Receive Cash Compensation". 2016-04-01
Bristol-Myers Squibb Company. (4/1/16). "Press Release: Bristol-Myers Squibb Completes Previously Announced Acquisition of Padlock Therapeutics, Inc.". New York, NY. 2016-04-01
Biogen Inc.. (4/1/16). "Press Release: Flixabi, an Infliximab Biosimilar Candidate Referencing Remicade, Receives Positive CHMP Opinion". Zug. 2016-04-01
Novartis AG. (3/31/16). "Press Release: Novartis Publishes Updated 2015 Segment Financials Reflecting New Division Structure". Basel. 2016-03-31
Roche. (3/31/16). "Press Release: Roche to Initiate Testing for Zika Virus at U.S. Blood Centres under FDA Investigational New Drug Application Protocol". Basel. 2016-03-31
Fusion Antibodies Ltd.. (3/31/16). "Press Release: Fusion Antibodies and MAB Discovery Announce Project Collaboration". 2016-03-31
Thermo Fisher Scientific Inc.. (3/31/16). "Press Release: Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders". Waltham, MA & Santa Clara, CA. 2016-03-31
Amal Therapeutics S.A.. (3/30/16). "Press Release: Amal Therapeutics Raises CHF 3 Million in a Series A Financing Round Led by Boehringer Ingelheim Venture Fund". Geneva & Ingelheim. 2016-03-30
Genohm. (3/30/16). "Press Release: Genohm Opens Its New US Branch in Durham, NC". Lausanne & Durham, NC. 2016-03-30
Affimed N.V.. (3/30/16). "Press Release: Affimed Reports Financial Results for Fourth Quarter and Year End 2015. Successful Financings Closed and US Presence Established". Heidelberg. 2016-03-30
CureVac AG. (3/30/16). "Press Release: CureVac Appoints Leading Experts to Its Scientific Advisory Board". Tübingen. 2016-03-30
Epigenomics AG. (3/30/16). "Press Release: Epigenomics Enters Strategic License and Development Agreement with BioChain on Novel, Blood-based Lung Cancer Test". Berlin & Germantown, MD. 2016-03-30
Evolva Holding S.A.. (3/30/16). "Press Release: Evolva Publishes Financial Results for 2015 and Updates on Projects". 2016-03-30
Boehringer Ingelheim. (3/30/16). "Press Release: Boehringer Ingelheim Venture Fund Invests in Amal Therapeutics to Develop Novel Therapeutic Colorectal Cancer Vaccine". Ingelheim & Geneva. 2016-03-30
4SC AG. (3/30/16). "Press Release: 4SC Announces Results for Financial Year 2015". Planegg-Martinsried. 2016-03-30
Editas Medicine, Inc.. (3/30/16). "Press Release: Editas Medicine Reports Fourth Quarter and Full Year 2015 Financial Results". Cambridge, MA. 2016-03-30
Selexis S.A.. (3/30/16). "Press Release: Selexis SA Announces Spring 2016 Conference Schedule". Geneva. 2016-03-30
Zavante Therapeutics, Inc.. (3/30/16). "Press Release: Zavante Therapeutics Closis $45 Million Series A Financing in Support of U.S. Development for a First-in-Class Injectable Antibiotic". San Diego, CA. 2016-03-30
Metabolon, Inc.. (3/29/16). "Press Release: Metabolon and Synlab Group Form Commercialization Collaboration for Quantose IR Diagnostic". Research Triangle Park, NC. 2016-03-29
Gadeta B.V.. (3/29/16). "Press Release: Gadeta Closes EUR 7 Million Series A Financing to Advance Novel Cancer Immunotherapies to the Clinic". Utrecht. 2016-03-29
Qiagen N.V.. (3/29/16). "Press Release: Qiagen to Submit Conditional Voluntary Takeover Offer for Shares of Exiqon A/S [Not for US, CA, JP, AU, ZA, et al.] Transaction will expand leadership position in RNA technologies". Venlo. 2016-03-29
Newron Pharmaceuticals S.p.A.. (3/29/16). "Press Release: Newron Receives Complete Response Letter from US FDA for Xadago (safinamide)". Milan. 2016-03-29
Ligand Pharmaceuticals Inc.. (3/28/16). "Press Release: Ligand Enters into OmniAb Platform License Agreement with ABBA Therapeutics". San Diego, CA. 2016-03-28
next pagenext page 1 2 3 ... 32 33 34 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top